See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Social Media
Tariffs
Natural Disasters
Donald Trump
Soccer
Real Madrid
South America
Golf
Tennis
Facebook
Trade
Published • loading... • Updated

Infectious Disease Treatments on FDA’s Watchlist for Q2 2025

Summary by contagionlive.com
Novavax’s COVID-19 vaccine, Merck’s RSV antibody, and Innoviva’s gonorrhea antibiotic await regulatory decisions this quarter.

1 Articles

All
Left
Center
Right
contagionlive.comcontagionlive.com

Infectious Disease Treatments on FDA’s Watchlist for Q2 2025

Novavax’s COVID-19 vaccine, Merck’s RSV antibody, and Innoviva’s gonorrhea antibiotic await regulatory decisions this quarter.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

contagionlive.com broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Merck

Merck

Vaccines

Vaccines

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal